UncategorizedNew Releases from NCBI BookshelfCritical Neurodiversity Studies: Divergent Textualities in Literature and Culture.Critical Neurodiversity Studies: Divergent Textualities in Literature and Culture. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfLorlatinib for ALK-positive advanced non-small-cell lung cancer that has not been treated with an ALK inhibitor.Lorlatinib for ALK-positive advanced non-small-cell lung cancer that has not been treated with an ALK inhibitor. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfSarilumab for treating polyarticular or oligoarticular juvenile idiopathic arthritis in people 2 to 17 years (terminated appraisal).Sarilumab for treating polyarticular or oligoarticular juvenile idiopathic arthritis in people 2 to 17 years (terminated appraisal). Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfClascoterone for treating acne vulgaris in people 12 years and over (terminated appraisal).Clascoterone for treating acne vulgaris in people 12 years and over (terminated appraisal). Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfDurvalumab for treating limited-stage small-cell lung cancer after platinum-based chemoradiotherapy.Durvalumab for treating limited-stage small-cell lung cancer after platinum-based chemoradiotherapy. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfIptacopan for treating complement 3 glomerulopathy (terminated appraisal).Iptacopan for treating complement 3 glomerulopathy (terminated appraisal). Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfMirabegron for treating neurogenic detrusor overactivity in people 3 to 17 years (terminated appraisal).Mirabegron for treating neurogenic detrusor overactivity in people 3 to 17 years (terminated appraisal). Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfGaradacimab for preventing recurrent attacks of hereditary angioedema in people 12 years and over.Garadacimab for preventing recurrent attacks of hereditary angioedema in people 12 years and over. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfWHO guidelines on the management of advanced HIV disease [Internet].WHO guidelines on the management of advanced HIV disease [Internet]. Leave a Comment / Uncategorized / admin Post Content